<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180128038541N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-02-13</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Effects of  exercises on inflammatory markers, anti-inflammatory markers, cross sectional area , muscle architecture, kinematic and kinetic parameters in  moderate hemophilia A patients</public_title>
      <acronym></acronym>
      <scientific_title>Effects of six weeks aerobic, resistance, and combined exercises on inflammatory markers, anti-inflammatory markers, cross sectional area , muscle architecture, kinematic and kinetic parameters in overweight moderate hemophilia A patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2017-10-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/29356</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: The probability sampling method is simple randomization.Randomization was performed by an external observer using closed envelopes in blocks of 8, each assigned to two subjects, Blinding description: The person collecting , determining the blood samples, sonography 
 and MRI measurements, kinematic parameters, kinetic parameters and data analyser and Data Saftey and Monitoring Committee are blinded to the grouping, but the physiotherapist for training( researcher) and participants is not masked to the group assignment.</study_design>
      <phase>3</phase>
      <hc_freetext>Moderate Hemophilia A.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: Resistanve exercise: Resistance training group require to perform six weeks trunk, upper and lower limb exercises (65-75% 1RM) , 40 min per session , three days per week.Strength-training exercises consist of knee flexion, knee extension, shoulder press, chest press, leg press, calf raise, and squat. Subjects perform 10 repetitions of each exercise during the first, third and fifth weeks and 12 repetitions of each exercise during the second, fourth and sixth weeks of training. Intervention 2: Intervention group 2: Aerobic exercise: Aerobic exercise  perform on treadmill   and cycle ergometer . Aerobic exercise intensity is adjusted based on maximum heart rate (220 - age = MHR).  In the first, second, and third of each two-week period, the target intensity is 65%, 70%, and 75% of MHR,respectively. Each exercise session consist of aerobic training on a treadmill for 22 minutes ,and cycle ergometer for 22 minutes. Each step include warm up, training at constant workload, and cool down. A 3-minute warm-up phase followed by 12 minutes training at constant workload phase and  a 2-minute cool down phase is  used for the aerobic exercises. Intervention 3: Intervention group3: Combined exercise:In the combined resistance with aerobic training group, the intensity of the resistance exercises is similar to that for the resistance training group, but there is five repetitions of each exercise in the first, third, and fifth weeks and six repetitions during the second, fourth, and sixth weeks of training. After 22 minutes of aerobic exercises, patients perform 20 minutes resistance exercises. Each exercise session consisted of aerobic training on a treadmill for 11 minutes ,and cycle ergometer for 11 minutes. Each step include warm up, training at constant workload, and cool down. A 3-minute warm-up phase followe by 6 minutes training at constant workload phase and  a 2-minute cool down phase is used for the aerobic exercises. Intervention 4: Control group: The control group is requested not to change their daily physical activity during the 6 weeks.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Information about serum markers, MSK sonography and MRI, kinematic and kinetic parameters

When:
Starting 6 months after publication

To whom:
Physiotherapist and orthopadist related with hemophilia patients

Conditions:
Coopration for article publishing using our data for investigation of effect of exercise with more duration on the muscle cross section area and architecture, kinematic and kinetic parameters

Where to obtain:
Behrouz Parhampour, first email and then call phone: 02144925035
behrouz.parhampour@gmail.com

How to obtain:
Sending email and answering within 2  next weeks

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Behnoosh Vasaghi Gharamaleki</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nezam Alley, Shahnazari Street, Mirdamad Street, School of Rehabilitation. IUMS</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913187</zip>
        <telephone>+98 21 2222 8051</telephone>
        <email>bvasaghi@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Behnoosh Vasagh Gharamaleki</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nezam Alley, Shahnazari Street, Mirdamad Street, School of Rehabilitation. IUMS</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913187</zip>
        <telephone>+98 21 2222 8051</telephone>
        <email>bvasaghi@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Men with moderate  haemophilia  A (factor VIII 1% -5 %)
Aged 35–55 years;
Body mass index 25–30 kg/m2;
No history of an inhibitor;
Total Hemophilia Joint Health Score (HJHS) ≤10
Factor VIII prophylaxis before and during treatment protocol</inclusion_criteria>
      <agemin>35 years</agemin>
      <agemax>55 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Clinical signs of active bleeding
Participation in regular physical training activities (more than two times per week) in the previous six months
High blood pressure at rest (systolic &gt;160 mmHg, diastolic &gt;10 mmHg)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>D66</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Hereditary factor VIII deficiency</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: Resistanve exercise: Resistance training group require to perform six weeks trunk, upper and lower limb exercises (65-75% 1RM) , 40 min per session , three days per week.Strength-training exercises consist of knee flexion, knee extension, shoulder press, chest press, leg press, calf raise, and squat. Subjects perform 10 repetitions of each exercise during the first, third and fifth weeks and 12 repetitions of each exercise during the second, fourth and sixth weeks of training.</i_keyword>
      <i_keyword>Intervention group 2: Aerobic exercise: Aerobic exercise  perform on treadmill   and cycle ergometer . Aerobic exercise intensity is adjusted based on maximum heart rate (220 - age = MHR).  In the first, second, and third of each two-week period, the target intensity is 65%, 70%, and 75% of MHR,respectively. Each exercise session consist of aerobic training on a treadmill for 22 minutes ,and cycle ergometer for 22 minutes. Each step include warm up, training at constant workload, and cool down. A 3-minute warm-up phase followed by 12 minutes training at constant workload phase and  a 2-minute cool down phase is  used for the aerobic exercises.</i_keyword>
      <i_keyword>Intervention group3: Combined exercise:In the combined resistance with aerobic training group, the intensity of the resistance exercises is similar to that for the resistance training group, but there is five repetitions of each exercise in the first, third, and fifth weeks and six repetitions during the second, fourth, and sixth weeks of training. After 22 minutes of aerobic exercises, patients perform 20 minutes resistance exercises. Each exercise session consisted of aerobic training on a treadmill for 11 minutes ,and cycle ergometer for 11 minutes. Each step include warm up, training at constant workload, and cool down. A 3-minute warm-up phase followe by 6 minutes training at constant workload phase and  a 2-minute cool down phase is used for the aerobic exercises.</i_keyword>
      <i_keyword>Control group: The control group is requested not to change their daily physical activity during the 6 weeks.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>IL-6:  Inflammatory marker. Timepoint: Before and after six weeks exercise. Method of measurement: ELISA kit, Invitrogen, San Diego,USA.</prim_outcome>
      <prim_outcome>TNF:  Inflammatory marker. Timepoint: Before and after six weeks exercise. Method of measurement: ELISA kit, Invitrogen, San Diego,USA.</prim_outcome>
      <prim_outcome>Hs-CRP:Inflammatory marker. Timepoint: Before and after six weeks exercise. Method of measurement: ELISA kit, Invitrogen, San Diego,USA.</prim_outcome>
      <prim_outcome>IL-10: Anti inflammatiry marker. Timepoint: Before and after six weeks exercise. Method of measurement: ELISA kit, Invitrogen, San Diego,USA.</prim_outcome>
      <prim_outcome>Adiponectine: Anti inflammatiry marker. Timepoint: Before and after six weeks exercise. Method of measurement: ELISA kit, Invitrogen, San Diego,USA.</prim_outcome>
      <prim_outcome>Muscle Thickness and pennation angle. Timepoint: Before and after six weeks exercise. Method of measurement: Ultrasonography, B mode.</prim_outcome>
      <prim_outcome>Muscle cross sectional area. Timepoint: Before and after six weeks exercise. Method of measurement: Axial plane scans using  MRI scanner.</prim_outcome>
      <prim_outcome>Angular displacement and velocity of the knee and hip joints  in three planes including sagital, frontal and transverse planes. Timepoint: Before and after six weeks exercise. Method of measurement: Marking the knee and hip joints and recording by the camera of the motion analysis (Vicon).</prim_outcome>
      <prim_outcome>Mean, standard deviation, total displacement and velocity of center of pressure during walking and sit to stand in the frontal and sagital planes. Timepoint: Before and after six weeks exercise. Method of measurement: Force plate (Kistler) With a sampling rate of 100 Hz.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-06-28</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Nezam Alley, Shahnazari Street, Mirdamad Street, School of Rehabilitation. IUMS Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
